NCT07457814

Brief Summary

This prospective observational study evaluates postoperative pain intensity and analgesic consumption in patients undergoing total knee arthroplasty (TKA) under different anesthesia techniques. Patients receive either general anesthesia with peripheral nerve block, spinal anesthesia with peripheral nerve block, spinal anesthesia alone, or general anesthesia with an epidural catheter. Pain scores (NRS), analgesic use, adverse effects, patient satisfaction, and the need for therapeutic interventions are assessed during the first 48 hours after surgery. The study aims to identify differences in postoperative pain control and factors associated with hypotension and other complications.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
12mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Mar 2026Jun 2027

First Submitted

Initial submission to the registry

February 24, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2027

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

February 24, 2026

Last Update Submit

March 4, 2026

Conditions

Keywords

Total Knee ArthroplastyPostoperative PainAnesthesia TechniquesAnalgesic ConsumptionEpidural AnalgesiaOpioid UseGeneral AnesthesiaSpinal AnesthesiaPain Management

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity

    Pain intensity will be assessed using the Visual Analog Scale (VAS) or Numerical Rating Scale (NRS) at predefined postoperative intervals. Both scales range from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores represent worse pain intensity.

    6 hours, 24 hours, and 48 hours after surgery

Secondary Outcomes (5)

  • Analgesic consumption

    First 48 hours after surgery

  • Adverse effects

    First 48 hours after surgery

  • Patient satisfaction

    48 hours after surgery

  • Length of hospital stay

    From the day of surgery (Day 0) through hospital discharge (typically 3-14 days).

  • Number of participants requiring therapeutic interventions

    Up to 48 hours after surgery.

Study Arms (4)

General Anesthesia + Peripheral Nerve Block (CA + PNB)

Patients undergoing total knee arthroplasty under general anesthesia combined with a peripheral nerve block. General anesthesia is induced using intravenous and inhalational agents. A peripheral nerve block (most commonly femoral or saphenous) is administered preoperatively to reduce postoperative pain and opioid requirements. This group represents a commonly used multimodal analgesic approach in routine clinical practice.

General Anesthesia + Epidural Catheter (CA + EDA)

Patients undergoing total knee arthroplasty under general anesthesia with an epidural catheter placed for intraoperative and postoperative analgesia. General anesthesia is induced using intravenous and inhalational agents. The epidural catheter allows continuous administration of analgesics and individualized dose adjustment to maintain postoperative pain control. This group represents a commonly used technique for providing extended regional analgesia following TKA.

Spinal Anesthesia + Peripheral Nerve Block (SA + PNB)

Patients undergoing total knee arthroplasty under spinal anesthesia supplemented with a peripheral nerve block. Spinal anesthesia is administered into the subarachnoid space to provide intraoperative analgesia. A peripheral nerve block (femoral or saphenous) is added to enhance postoperative pain control and reduce the need for systemic analgesics. This combination represents a commonly used multimodal analgesic strategy.

Spinal Anesthesia (SA)

Patients receiving spinal anesthesia alone without an additional peripheral nerve block. Spinal anesthesia provides sensory and motor blockade of the lower body during surgery. This group allows evaluation of postoperative pain and analgesic requirements in patients managed with spinal anesthesia as the sole regional technique.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients aged 18-100 years undergoing primary total knee arthroplasty at Krajská nemocnice T. Bati, a. s. Patients must have ASA physical status I-III, GCS 15, ability to understand the study procedures, and provide informed consent. Only patients capable of cooperation during pre-anesthetic evaluation and without severe sensory impairment are included.

You may qualify if:

  • Age 18-100 years
  • Primary total knee arthroplasty (TKA)
  • ASA physical status I-III
  • Glasgow Coma Scale (GCS) score of 15
  • Ability to understand study procedures and provide informed consent
  • Ability to cooperate during pre-anesthetic evaluation
  • No severe sensory impairment (e.g., blindness, deafness)

You may not qualify if:

  • Revision or reoperation of TKA
  • ASA score IV or higher
  • Refusal to participate or inability to provide informed consent
  • GCS ≤ 14
  • Limited legal capacity
  • Active psychiatric disorder
  • Chronic use of strong opioid analgesics
  • Neurological disease affecting pain perception or cooperation
  • Cognitive impairment or language barrier preventing questionnaire completion
  • Use of anesthesia techniques other than GA + PNB or SA + PNB (e.g., epidural anesthesia, local infiltration without PNB)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tomas Bata regional hospital

Zlín, 76001, Czechia

Location

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Central Study Contacts

Klára Nekvindová, MD, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research Lead, omas Bata Hospital

Study Record Dates

First Submitted

February 24, 2026

First Posted

March 9, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

June 15, 2027

Last Updated

March 9, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

"Individual participant data will not be shared because the study involves sensitive clinical information and no data-sharing plan was included in the ethics committee approval. Data will be used exclusively for the purposes of this study."

Locations